CJC-1295-no-DAC-+-IPA 20MG – A Comprehensive Research Overview
CJC-1295-no-DAC-+-IPA is a synthetic analog of Growth Hormone-Releasing Hexapeptide (GHRH). It is used in research settings to explore its effects on growth hormone (GH) release and its potential applications. This product is specifically formulated without the dacarbazine component, which enhances its stability and usability in various biochemical assays.
Research Context
The compounds CJC-1295-no-DAC-+-IPA has been a subject of interest due to its ability to stimulate the release of growth hormone. This effect is mediated through binding to GHRH receptors, which can lead to increased levels of GH in circulation. Research involving this compounds often focuses on understanding its mechanism of action, evaluating its efficacy and safety profiles, and exploring its potential applications in various biological contexts.
Research Overview
This product is designed for use in research environments where the precise control over growth hormone release is critical. It serves as a valuable tool for scientists working on understanding the physiological mechanisms of growth hormone regulation and its role in various diseases and conditions. The compounds enhanced stability, provided by the absence of DAC, makes it suitable for a wide range of experimental protocols.
Key Research Focus Areas
- Evaluation of CJC-1295-no-DAC-+-IPA’s effect on growth hormone release in different cell types and tissues
- Determination of the optimal conditions for compound administration in various assays
- Investigation into potential synergistic effects when combined with other compounds or hormones
- Analysis of the pharmacokinetic properties of CJC-1295-no-DAC-+-IPA in model organisms
- Study of the long-term stability and shelf life of the compound under different storage conditions
Final Compliance Disclaimer Paragraph
Please note that this product is for research use only. Not for human or animal consumption.
| Size | 20MG |
|---|
